Apolipoprotein B and low density lipoprotein size in type two diabetes: effect of atorvastatin and gemfibrozil
Phase of Trial: Phase II
Latest Information Update: 01 Jul 2011
At a glance
- Drugs Atorvastatin (Primary) ; Gemfibrozil (Primary)
- Indications Dyslipidaemias
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 01 Jul 2011 Results published in Diabetes Research and Clinical Practice.
- 09 Jul 2007 New trial record.